Gov. Greg Abbott's speech sets a broad agenda for the Legislature, including a nuclear renaissance and a Texas Cyber Command.

In a report released today, Larry Biegelsen from Wells Fargo maintained a Buy rating on Stryker (SYK – Research Report), with a price target of ...

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

The Aussie dollar’s decline is not yet factored into consensus ASX earnings forecasts, which will benefit some stocks and ...

Stocks like Emami, Piramal Enterprises, Prudent Corporate Advisory Services, Updater Services, Railtel Corporation of India, ...

The benchmark indices may attempt to rebound amid rangebound trading and rising volatility. Below are some trading ideas for ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories (NYSE: ABT) is a well-diversified health care company, with four distinct units: medical devices, ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

With a trading volume of 5,249,687, the price of ABT is down by -0.19%, reaching $122.98. Current RSI values indicate that ...